Clinical Trials Logo

Telemedicine clinical trials

View clinical trials related to Telemedicine.

Filter by:

NCT ID: NCT05193825 Recruiting - Parkinson Disease Clinical Trials

Evaluation of Remote DBS Programming.

REMOTE
Start date: March 22, 2022
Phase: N/A
Study type: Interventional

Deep brain stimulation (DBS) represents the treatment of choice for advanced stages of Parkinson's disease (PD). Currently, adaptive closed-loop stimulation systems that apply disease-specific biomarkers, such as local field potentials (LFPs), are being actively examined to facilitate DBS programming. However, the most suitable feedback signal, still remains to be determined. The investigators previously tested the usefulness of the patient's subjective rating on a visual analogue scale (VAS) as a potential feedback signal for DBS adjustment and found that VAS-based programming lead to similar results as our standard approach. One of the practical advantages of using VAS-based programming strategies - in addition to saving time - is the principal applicability of such an approach to a remote programming setting, although a validation of such an approach is required. Within the scope of a prospective, randomized multicenter clinical trial (the REMOTE Trial), the investigators will examine the effectiveness and safety of VAS-based remote DBS programming in PD by using a novel and recently introduced software platform (Abbott NeurosphereTM Virtual Clinic) that allows for the programming through a smartphone-based video connection with the patient. Therefore, n = 50 PD patients undergoing STN-DBS surgery will be randomized and subsequent to surgery will have their IPG settings adjusted either during regular visits at the hospital or alternatively be programmed remotely through a VAS-based approach. Prior to surgery and after a 90 days follow-up period, we will assess specific clinical (MDS-Unified Parkinson's Disease Rating Scale = UPDRS, Parkinson's Disease Questionnaire-39 sum index = PDQ-39 SI, Beck Depression Inventory = BDI, Montreal Cognitive Assessment Scale = MOCA) parameters to determine the effectivity and safety of the two different strategies on the patient outcome and to correlate it with VAS ratings and MRI data. The results will support the examination of remote-based DBS programming and evaluate the patient's subjective judgment as a valid feedback signal.

NCT ID: NCT05147038 Completed - Telemedicine Clinical Trials

The Impact of Tele-coaching on the Physical Activity Level

Start date: September 14, 2021
Phase: N/A
Study type: Interventional

The study aims to test the benefits of a semi-automated tele-coaching program to coach adult participants with chronic lung disease towards a more active lifestyle.

NCT ID: NCT05134636 Completed - Cancer Clinical Trials

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care

TIME
Start date: December 6, 2021
Phase: N/A
Study type: Interventional

The primary objective is to test whether a text-based e-triage can safely minimize the time associated with routine cancer care by identifying patients who can proceed directly to their immunotherapy infusion without a preceding in-person office assessment.

NCT ID: NCT05106439 Completed - Telemedicine Clinical Trials

Intern Health Study: 2020 Cohort Micro-Randomized Trial

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of gamified competition (delivered through a smartphone) for improving the physical activity and sleep of medical interns.

NCT ID: NCT05087082 Completed - Telemedicine Clinical Trials

Early Transfer of Hospitalized Patients Incl. COVID-19 to a Virtual Hospital at Home Model - a Clinical Feasibility Study

Influenz-er
Start date: April 20, 2022
Phase: N/A
Study type: Interventional

This study will be part of a larger, 'virtual hospital-at-home' (vHaH) project called Influenz-er. vHaH is a care model designed to deliver medical care in the home, as a substitute for a continued inpatient hospital admission. This study will be a clinical feasibility study, which will be used to guide the framing and design of the final telemedicine supported vHaH model for hospitalized patients.

NCT ID: NCT05046392 Recruiting - HIV Clinical Trials

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV

Super SMART
Start date: October 6, 2021
Phase: N/A
Study type: Interventional

HIV medications can be very effective at helping patients have longer, healthier lives. However, many patients do not take their HIV medications as prescribed. This study aims to test a promising HIV medication adherence health coaching intervention delivered primarily via a smartphone application. N = 400 persons living with HIV will be enrolled across two sites (Providence, RI & Atlanta, GA). Participants will be randomly assigned, with a 2:1 ratio, to receive a 1) health coaching session with access to a smartphone application that provides medication reminders and remote access to the health coach or a 2) health coaching session only. Participants will complete interviews at baseline, 1, 3, 6, and 12 months after baseline. Some participants will also complete interviews at 18 and 24 months after baseline. Data analysis will examine the extent to which the intervention improves ART medication adherence, as well as other factors, compared to the control condition, which approximates standard of care.

NCT ID: NCT05043220 Active, not recruiting - Telemedicine Clinical Trials

Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy

CO-SI-ONKO
Start date: September 29, 2021
Phase: N/A
Study type: Interventional

We designed a monocenter prospective cohort study using PROM via app and remote monitoring via pho-toplethysmography (PPG). The application of these technologies enables an early detection of infections and therefore initiation of medical interventions. The study is conducted as feasibility analysis; primary endpoints are adherence (according to wearing time) and technical robustness.

NCT ID: NCT05030935 Completed - Pressure Ulcer Clinical Trials

Assessing the Feasibility of a Prevention m-Health App Intervention for Informal Caregivers of Outpatients

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The present quasi-experimental study aims to compare the level of preventive behaviours amongst caregivers who will be instructed to operating one mHealth App or given a relevant instruction manual. To achieve this, a comparison between the behavior of caregivers before and after the intervention and a comparison between the two groups (intervention group with the control group) will be performed. Specifically, data within the two groups will be collected via an online questionnaire consisting of three parts: prior to the intervention (baseline), two (2) and four (4) months after the intervention. The self-administered questionnaire consists of fifty-two (52) questions and uses three valid and reliable scales with a part that was developed via a bibliography research and consultations from experienced specialists. The questionnaire scales have been translated from the English language to Greek.

NCT ID: NCT05025891 Recruiting - HIV Clinical Trials

ISe-santé, a Study Evaluating a Model for Implementing E-health in the Management of HIV Patients

Start date: February 4, 2021
Phase: N/A
Study type: Interventional

It is a randomized, controlled, open-label, parallel group study of 3 arms, among patients followed for chronic HIV infection at Cayenne hospital. The main objective of the study is to evaluate the effectiveness of follow-up of these patients by teleconsultation associated or not with health mediation.

NCT ID: NCT05015933 Completed - Telemedicine Clinical Trials

Intrathecal Pump Refills at Home

Start date: August 9, 2021
Phase: N/A
Study type: Interventional

The aim of this pilot study is to evaluate the feasibility, safety and effectiveness of intrathecal pump refill procedures at home. It is our hypothesis that a refill at home will be safe, effectiveness and feasible, as is demonstrated in The Netherlands, and preferred by patients.